Glutamatergic and GABAergic Mediators of Antidepressant Response in Major Depression
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01557946|
Recruitment Status : Completed
First Posted : March 20, 2012
Results First Posted : September 12, 2017
Last Update Posted : September 12, 2017
|Study Design||Allocation: Non-Randomized; Intervention Model: Single Group Assignment; Masking: None (Open Label); Primary Purpose: Treatment|
Major Depressive Disorder
Modest sample size due to participant attrition and the cost and logistical challenges of the study design.
Multiple comparisons, increasing the likelihood of type I errors. Open-label design which leaves open the possibility of a placebo effect.